Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 23.9 M31.88 M32.61 M33.2 M54.96 M 152.66 M Research & development ————— — Operating income 328.87 M344.76 M372.15 M329.12 M330 M 1.38 B Non-Operating Income, Total 7.79 M6.8 M17.9 M-389 K34 M 58.31 M Interest expense, net of interest capitalized 87.76 M86.58 M87.94 M85.78 M73.34 M 333.64 M Non-Operating Income, excl. Interest Expenses -79.97 M-79.78 M-70.04 M-86.17 M-39.34 M -275.33 M Unusual income/expense ————— — Pretax income 57.65 M49.47 M60.8 M53.14 M50.44 M 213.86 M Equity in earnings 42.7 M-3.99 M1.02 M6.94 M241 K 4.21 M Taxes 13.11 M11.58 M14.13 M10.22 M11.43 M 47.35 M Non-controlling/minority interest 2.42 M1.82 M856 K1.34 M1.18 M 5.2 M After tax other income/expense -3.31 M-3.87 M-3.73 M-3.41 M-3.08 M -14.1 M Net income before discontinued operations 42.12 M36.07 M45.82 M41.58 M37.84 M 161.31 M Discontinued operations ————— — Net income 42.12 M36.07 M45.82 M41.58 M37.84 M 161.31 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 42.12 M36.07 M45.82 M41.58 M37.84 M 161.31 M Basic earnings per share (Basic EPS) 0.650.570.740.690.64 2.64 Diluted earnings per share (Diluted EPS) 0.650.570.740.690.64 2.64 Average basic shares outstanding 64.61 M63.64 M62.15 M62.7 M59.12 M — Diluted shares outstanding 64.61 M63.64 M62.17 M62.71 M59.21 M — EBITDA 241.29 M258.44 M298.31 M249.36 M254.8 M 1.06 B EBIT 241.19 M258.26 M284.28 M247.83 M254.46 M 1.04 B Cost of revenue 9.34 M-7.34 M-2.51 M7.82 M1.76 M -262 K Other cost of goods sold ————— — Depreciation & amortization (cash flow) 84 K84 K84 K1.11 M345 K 1.62 M